Yaru Tian

Mar 11, 2024 | nature.com | Di Wu |Yong Li |PengFei Xu |Fei Cao |Yaru Tian |Xinrui Zhang | +1 more

AbstractNeoadjuvant chemoimmunotherapy has emerged as a potential treatment option for resectable head and neck squamous cell carcinoma (HNSCC). In this single-arm phase II trial (NCT04826679), patients with resectable locally advanced HNSCC (T2‒T4, N0‒N3b, M0) received neoadjuvant chemoimmunotherapy with camrelizumab (200 mg), nab-paclitaxel (260 mg/m2), and cisplatin (60 mg/m2) intravenously on day one of each three-week cycle for three cycles.

Apr 28, 2023 | mdpi.com | Wenbo Shi |Haoyu Bai |Yaru Tian |Xinsheng Wang

Abstract:The rational design of superhydrophilic materials with a controllable structure is a critical component in various applications, including solar steam generation, liquid spontaneous transport, etc. The arbitrary manipulation of the 2D, 3D, and hierarchical structures of superhydrophilic substrates is highly desirable for smart liquid manipulation in both research and application fields.